Table 2.

Overall and compliant use of services stratified by year the NCCN guidelines for non-muscle-invasive bladder cancer were established.

	Mean (SD)			Number Compliant (%)
Quality-of-Care Measures	1992–1997	1998–2002	p-value	1992–1997	1998–2002	p-value
Cystoscopy	4.73 (2.07)	4.86 (2.02)	0.04	84 (4.6%)	143 (4.8%)	0.81
Cytology	2.26 (2.75)	2.24 (2.65)	0.80	98 (5.4%)	143 (4.8%)	0.34
Upper tract imaging	1.81 (1.50)	1.97 (1.64)	<0.001	1582 (87.4%)	2610 (87.5%)	0.92
Mitomycin C	1.63 (3.50)	1.08 (3.00)	<0.001	50 (2.8%)	95 (3.2%)	0.41
BCG	3.76 (5.16)	4.89 (5.38)	<0.001	235 (13.0%)	586 (19.7%)	<0.001